ABSTRACT

Radical prostatectomy remains to be the most common treatment modality for clinically localized prostate cancer, and robotic radical prostatectomy has become an alternative popular option since it was introduced in 2000 against open prostatectomy. Current studies suggest that oncologic outcomes of robotic prostatectomy are comparable with open surgery. Moreover, robotic prostatectomy appears to have better outcomes in terms of continence and protection of erection compared with open surgery. Therefore, quality of life assessment is required between these two surgical modalities in order to compare these options. However, methodological limitations in measuring quality of life exist in current clinical studies to reach a conclusion.